Cancer researcher Judah Folkman has died, the New York Times reports. Known as the "father of the idea that tumors can be kept in check by choking off the supply of blood they need to grow," his work led to the development of several anti-angiogenic drugs, including Genentech’s Avastin. Dr. Joan Bushwell writes a nice biographical profile of Folkman here.
Goodbye to Cancer Pioneer Judah Folkman
Jan 17, 2008